Award details

Dietary modulation of immune function in relation to type 2 diabetes and cardiovascular disease risk

ReferenceBBS/E/F/00041694
Principal Investigator / Supervisor Dr David Hughes
Co-Investigators /
Co-Supervisors
Institution Quadram Institute Bioscience
DepartmentQuadram Institute Bioscience Department
Funding typeResearch
Value (£) 354,578
StatusCompleted
TypeInstitute Project
Start date 01/04/2003
End date 31/03/2005
Duration24 months

Abstract

Cardiovascular disease (CVD) is a major cause of mortality in the UK and is likely to rise further given the increasing prevalence of obesity and related rise in the incidence of Type 2 diabetes. Diabetes is associated with an increased risk of early-onset atherosclerosis (thickening of the artery walls). This is now recognised as an inflammatory disease occurring in all adults to a greater or lesser extent. Monocytes and T lymphocytes (mononuclear cells) are crucial cell types in the genesis of the atherosclerotic lesion and are present during all stages of disease progression. In terms of reduced CVD risk, numerous epidemiological & prospective studies have indicated beneficial effects of increased vitamin E and n-3 fatty acid intake, as well as of increased fruit and vegetable consumption. In collaboration with the Diabetes Research Centre, Norfolk & Norwich University Hospital, we will examine differences in mononuclear cell function, at the molecular and cellular level, between healthy volunteers and patients with Type 2 diabetes, and investigate novel mechanisms of the beneficial effects of dietary components, in terms of reducing CVD risk, on human immune cell function

Summary

unavailable
Committee Closed Committee - Agri-food (AF)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file